Masamune Hiroko 4
4 · Viking Therapeutics, Inc. · Filed Jul 3, 2018
Insider Transaction Report
Form 4
Masamune Hiroko
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-07-01+42,000→ 42,000 totalExercise: $9.49From: 2019-07-01Exp: 2028-07-01→ Common Stock (42,000 underlying) - Award
Common Stock, par value $0.00001 per share
2018-07-01+15,000→ 111,197 total
Footnotes (2)
- [F1]Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award.
- [F2]One-third of the shares subject to the option will vest on each one year anniversary of the grant date.